Postgrad Med (2020) 132(sup2):314
For eligible beneficiaries, the ultimate result is simple: a fixed $50 monthly copay for cutting-edge weight-loss medications
In fact, during the two-week "Lose It" period, you can safely drop between 6 and 10 pounds
Using both immortalised and primary human cells, liraglutide, acyl-GIP, and a dual GLP-1/GIP receptor agonist (MAR709) failed to produce measurable effects on lipid accumulation, fibrogenic gene expression, or CREB phosphorylation at physiologically relevant concentrations
A pilot trial finds sulforaphane treatment increases glutathione levels in the brain
Continued Growth in GLP-1 Compounding Despite Regulatory Headwinds Despite the resolution of GLP-1 shortages and increased regulatory scrutiny, compounded prescriptions for semaglutide and tirzepatide continue to rise